TP53 and myeloproliferative neoplasm: Indeed, in MPN the first acquired mutations always affect driver genes or epigenetic factors and TP53 mutations are acquired late during disease evolution, often in a clone carrying a driver mutation or, when several TP53 mutations are acquired, they occur in different cells [40].